Aldosterone receptor antagonists in cardiovascular disease: a review of the recent literature and insight into potential future indications.

about

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.Role of mineralocorticoid receptor antagonists in cardiovascular disease.

P2860

Q34464759-1CB06517-AF46-44A9-A143-76AD2076979B Q34762461-1D2EB4E5-1492-478D-BB10-C49703207B36 Q34817129-A1AB6EA9-1D09-40FA-BB94-8502C7AEDFE3

P2860

Aldosterone receptor antagonists in cardiovascular disease: a review of the recent literature and insight into potential future indications.

Item

http://www.wikidata.org/entity/Q38025063

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Aldosterone receptor antagonis ...... potential future indications.

@en

type

Item

label

Aldosterone receptor antagonis ...... potential future indications.

@en

prefLabel

Aldosterone receptor antagonis ...... potential future indications.

@en

P1476

Aldosterone receptor antagonis ...... o potential future indications

@en

P2093

Frank Messineo

http://www.w3.org/2001/XMLSchema#string

Mindy Markowitz

http://www.w3.org/2001/XMLSchema#string

Neil L Coplan

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.

Aldosterone receptor antagonists: effective but often forgotten.

Aldosterone and myocardial fibrosis in heart failure.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Aldosterone in congestive heart failure.

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Eplerenone: cardiovascular protection.

Early recognition and treatment of hypertensive heart disease.

Aldosterone receptor antagonists in the medical management of chronic heart failure.

P304

605-609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.22025

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229015198

http://www.w3.org/2001/XMLSchema#string

P698

22778046

http://www.w3.org/2001/XMLSchema#string

P932

6652403

http://www.w3.org/2001/XMLSchema#string

Aldosterone receptor antagonists in cardiovascular disease: a review of the recent literature and insight into potential future indications.

about

P2860

P2860

Aldosterone receptor antagonists in cardiovascular disease: a review of the recent literature and insight into potential future indications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932